Differential SHH, FGF10, and FGFR2 Expression Governs Penile Development: Insights from Guinea Pig and Mouse Models

Study Background and Research Question

Penile development in mammals is a complex, tightly regulated process involving the coordinated action of several morphogens, notably Sonic Hedgehog (SHH), Fibroblast Growth Factor 10 (FGF10), and its receptor FGFR2. While the mouse model has long served as the foundation for understanding urogenital morphogenesis, anatomical studies reveal notable differences in penile development between mice, guinea pigs, and humans. In particular, the formation of the prepuce and urethral groove—a precursor to the penile urethra—follows divergent morphogenetic patterns. The reference study (Wang & Zheng, 2025) addresses the mechanistic basis of these species-specific differences, focusing on the temporal and spatial expression of Shh, Fgf10, and Fgfr2 during genital tubercle development.

Key Innovation from the Reference Study

The central innovation of this work lies in its comparative analysis of penile development between guinea pigs and mice, directly examining how differential gene expression patterns drive divergent morphogenetic outcomes. Unlike prior studies that extrapolate mouse-based findings to other mammals, this research systematically quantifies and localizes Shh, Fgf10, and Fgfr2 transcripts, revealing that lower expression levels of these genes in guinea pigs may underlie the formation of a fully open urethral groove—a feature shared with humans but absent in mice (Wang & Zheng, 2025).

Methods and Experimental Design Insights

The investigators employed a combination of in situ hybridization and quantitative PCR to map gene expression in the developing genital tubercle (GT) across both species. Tissue samples were collected at key embryonic stages corresponding to glans and preputial development. The study also utilized organ culture assays: mouse GTs were treated with hedgehog and FGF pathway inhibitors to dissect pathway contributions, while guinea pig GTs were cultured with exogenous SHH and FGF10 proteins to assess their capacity to induce preputial morphogenesis. Morphological outcomes were evaluated with detailed histological analysis, allowing for precise correlation between gene expression changes and tissue architecture.

Core Findings and Why They Matter

The study found that in mice, preputial development initiates before sexual differentiation, with robust expression of Shh and Fgf10 in the genital tubercle. In contrast, guinea pig preputial formation is delayed until the onset of sexual differentiation and exhibits more than a fourfold reduction in Shh, Fgf8, Fgf10, Fgfr2, and Hoxd13 expression compared to mice. Notably, Fgf10 expression in guinea pigs is largely restricted to the urethral epithelium, paralleling patterns seen in humans.

Functional organ culture experiments revealed that inhibition of the hedgehog or FGF pathways in mouse GTs induced the formation of an open urethral groove and suppressed preputial development. Conversely, applying exogenous SHH or FGF10 to guinea pig GTs promoted preputial formation. This demonstrates a direct, causative role for SHH and FGF10/FGFR2 signaling in orchestrating the balance between urethral groove formation and prepuce outgrowth (Wang & Zheng, 2025).

These findings are significant for several reasons. First, they challenge the universality of mouse-derived models for human urogenital development, highlighting the need for species-appropriate experimental systems in congenital malformation research. Second, they clarify the molecular underpinnings of the "Double Zipper" model of human penile development, in which the urethral groove forms and then closes through a distal-to-proximal process—a mechanism absent in mice but present in guinea pigs and humans. This insight is critical for interpreting the etiology of congenital penile malformations and for designing translational studies.

Comparison with Existing Internal Articles

Several recent analyses have explored the functional roles of SHH protein in mammalian development. For example, internal work has emphasized the translational value of Recombinant Mouse Sonic Hedgehog in probing species-specific mechanisms of urogenital patterning. These articles consistently note the importance of SHH in congenital malformation research and its utility in both limb and brain patterning studies.

Moreover, a mechanistic review synthesizes how recombinant SHH protein enables precisely controlled induction of hedgehog signaling in developmental biology workflows, including the use of the alkaline phosphatase induction assay to verify activity. These perspectives are supported by the reference study’s demonstration that exogenous SHH protein can recapitulate aspects of preputial morphogenesis in guinea pig organ cultures.

Comparative insights are further elaborated in internal resources that underscore how differential SHH, FGF10, and FGFR2 expression underlies species-specific penile development, reinforcing the current study’s conclusions.

Limitations and Transferability

While the study provides strong evidence for the regulatory roles of SHH, FGF10, and FGFR2 in penile morphogenesis, several limitations merit discussion. The findings are based on embryonic stages in mice and guinea pigs, and although parallels are drawn to human development, direct human tissue data remain limited. The reliance on ex vivo organ cultures, while powerful for mechanistic dissection, may not capture the full complexity of in vivo signaling crosstalk or systemic hormonal influences.

Additionally, while the study implicates the hedgehog signaling pathway as a central regulator, it does not address potential compensatory mechanisms or the involvement of other morphogens in species where SHH expression is low. The transferability of these findings to clinical contexts or other model organisms should therefore be approached with caution, and further studies in human-relevant systems are warranted.

Protocol Parameters

• Embryonic stage selection: Collect genital tubercle tissue at defined developmental timepoints (e.g., E13.5–E15.5 for mice) to capture key morphogenetic transitions.
• Gene expression analysis: Use in situ hybridization and quantitative PCR to quantify Shh, Fgf10, and Fgfr2 mRNA in dissected tissues.
• Organ culture treatment: For functional tests, culture GT explants with recombinant SHH or FGF10 protein at concentrations empirically determined to elicit morphogenetic responses (typically in the range of 0.5–1.0 μg/ml for SHH, as supported by the product information).
• Pathway inhibition: Apply validated hedgehog or FGF pathway inhibitors at published concentrations to dissect signaling contributions (see reference study for details).
• Histological analysis: Fix and section tissues post-culture to assess urethral groove and prepuce morphology.

Research Support Resources

For researchers seeking to model SHH pathway function in limb and brain patterning studies or to induce specific morphogenetic outcomes in organ culture, Recombinant Mouse Sonic Hedgehog (SKU P1230) from APExBIO offers a standardized, biologically active source of SHH protein. Its activity is confirmed by induction of alkaline phosphatase in murine C3H10T1/2 cells, and protocol guidance is provided for use in developmental biology research. Integration of recombinant SHH in experimental workflows can help recapitulate or dissect pathway-specific effects observed in comparative developmental studies such as those by Wang & Zheng (2025).